Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 9/16 August 2014, Vol 293, No 7822/3

Sort by: Newest first Oldest first A-Z Z-A

  • Lamisil cream discontinued Subscription

    5 AUG 2014 10:25

    Novartis has discontinued Lamisil (terbinafine hydrochloride) cream 15g. Lamisil cream 30g is unaffected. Further information is available on 01276 687202.

  • AWMSG decisions Subscription

    5 AUG 2014 10:13

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): eltrombopag to treat thrombocytopenia in adults with hepatitis C infection where the degree of thrombocytopenia is compromising the efficacy of interferon; imatinib for adjuvent treatment of KIT-positive gastrointestinal stromal tumours; Eviplera (emtricitabine, rilpivirine and tenofovir; Gilead) for treatment-experienced adults infected with HIV type 1; and velaglucerase ...

  • Bonviva tablets discontinued Subscription

    5 AUG 2014 9:36

    Roche has discontinued Bonviva (ibandronic acid) tablets 150mg x 3. The single tablet packs and the pre-filled syringe 3mg/ml will continue to be available. Medical information on 0800 328 1629.

  • Rivotril tablets discontinued Subscription

    5 AUG 2014 9:34

    Roche will discontinue Rivotril (clonazepam) tablets 0.5mg and 2mg on 31 August 2014. Medical information on 0800 328 1629.

  • Revised malaria prevention guidelines for UK travellers Subscription

    5 AUG 2014 9:27

    Public Health England (PHE) has updated its guidance on malaria prevention for healthcare professionals advising those travelling from the UK to malaria-endemic areas. The guidance is available from the PHE website.

  • The RPS policy on assisted suicide addresses many questions Subscription

    4 AUG 2014 18:00 By Charles Willis, Aileen Bryson
    Comments (1)

    Although it was good to see an update on the progress of the Westminster private members’ bill on assisted dying reported in last weeks’ editorial (2014;293:98) we were disappointed that no mention was made of the Royal Pharmaceutical Society policy and the amount of work RPS staff have already undertaken to support the profession, should this legislation be passed. 

  • Frederick Norman Harrison dies Subscription

    4 AUG 2014 14:22

    On 22 July, Frederick Norman Harrison, aged 98, of 127 Main Road, Drax, Selby, North Yorkshire YO8 8NJ. Mr Harrison registered in 1938 and left the Society in 2007.

  • Derek Mace dies Subscription

    4 AUG 2014 14:21

    On 15 July, Derek Mace, aged 87, of Alwoodley, Hollytree Road, Woolton, Liverpool L25 5PA. Mr Mace registered with the Society in 1953.

  • Anopheles minimus, mosquito causing malaria

    Artemisinin-resistant malaria ‘widespread’ in Southeast Asia

    1 AUG 2014 14:40 By Joanna Lyford

    Researchers call for radical measures to prevent resistance to the most effective type of antimalarial agent spreading to the Indian subcontinent and beyond.

  • Launch of new treatment for chronic obstructive pulmonary disease (COPD)

    New treatment for chronic obstructive pulmonary disease

    31 JUL 2014 16:28 By Janna Lawrence

    Olodaterol, a once-daily long acting beta2 agonist inhaler, has been launched in the UK for chronic obstructive pulmonary disease.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.